Literature DB >> 24835039

Autoimmune pancreatitis: updated concepts of a challenging diagnosis.

Brian Morse1, Barbara Centeno2, Shivakumar Vignesh3.   

Abstract

Autoimmune pancreatitis is a benign process characterized by inflammation and fibrosis. It is now known that cases of "autoimmune pancreatitis" actually consist of two distinct pathologic entities. Type 1 autoimmune pancreatitis is a manifestation of a systemic process, immunoglobulin G subclass 4 (IgG4)-related disease. IgG4-related disease can affect virtually every organ system in the body. Type 1 affects older patients and is characterized by an elevated serum IgG4 level and sites of extrapancreatic disease. Type 2 autoimmune pancreatitis is a disease process confined to the pancreas. It affects younger patients and is associated with inflammatory bowel disease. Type 2 is not associated with elevated IgG4 levels or extrapancreatic disease. Both subtypes can mimic malignancy, particularly pancreatic cancer. Awareness of the clinical and imaging features of the subtypes of autoimmune pancreatitis is important to avoid an incorrect diagnosis of malignancy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune pancreatitis; IgG4-related disease; Type 1 autoimmune pancreatitis; Type 2 autoimmune pancreatitis

Mesh:

Substances:

Year:  2014        PMID: 24835039     DOI: 10.1016/j.amjmed.2014.04.033

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  2 in total

Review 1.  The role of regulatory B cells in digestive system diseases.

Authors:  Zhenyu Zhou; Lei Gong; Xiaoyun Wang; Zhen Hu; Gaojue Wu; Xuejun Tang; Xiaobin Peng; Shuan Tang; Miao Meng; Hui Feng
Journal:  Inflamm Res       Date:  2016-11-22       Impact factor: 4.575

2.  The challenging diagnosis of pancreatic masses: not all tumors are cancers.

Authors:  Alessandro Morotti; Dario Gned; Leonardo Di Martino; Gaetano Cristaldi; Anna Alì; Paolo Nicoli; Andrea Veltri; Angelo Guerrasio
Journal:  Case Rep Med       Date:  2015-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.